Search

Your search keyword '"serogroup C"' showing total 283 results

Search Constraints

Start Over You searched for: Descriptor "serogroup C" Remove constraint Descriptor: "serogroup C"
283 results on '"serogroup C"'

Search Results

1. Expansion of Neisseria meningitidis Serogroup C Clonal Complex 10217 during Meningitis Outbreak, Burkina Faso, 2019

2. Antimicrobial susceptibility profiles and genotyping of Neisseria meningitidis of serogroup C, Italy, 2000--2020.

3. Antimicrobial susceptibility profiles and genotyping of Neisseria meningitidis of serogroup C, Italy, 2000–2020

4. Development of a measure to assess vaccine confidence among men who have sex with men

5. Lipooligosaccharide Structures of Invasive and Carrier Isolates of Neisseria meningitidis Are Correlated with Pathogenicity and Carriage*

6. Meningococcemia por serogrupo C en un lactante Reporte de caso.

7. Expansion of Neisseria meningitidis Serogroup C Clonal Complex 10217 during Meningitis Outbreak, Burkina Faso, 2019.

8. A New Sequence Type of Neisseria meningitidis Serogroup C Associated With a 2016 Meningitis Outbreak in Mali.

9. Risk Factors for Serogroup C Meningococcal Disease during Outbreak among Men who Have Sex with Men, New York City, New York, USA

10. Sequence Type 4821 Clonal Complex Serogroup B Neisseria meningitidis in China, 1978–2013

11. Epidemics of meningococcal meningitis in Northern Nigeria focus on preventive measures.

12. Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis sequence type 4821: The first case in Japan.

13. Immunogenicity and Safety of a Two-Dose Series of a Meningococcal (Groups A, C, W, and Y) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Men-ACWY-D) in Healthy Japanese Adults

14. Evolution of Sequence Type 4821 Clonal Complex Hyperinvasive and Quinolone-Resistant Meningococci

15. Three Outbreak-causing Neisseria meningitidis Serogroup C Clones, Brazil

16. Serogroup C invasive meningococcal disease in the post-vaccine era and vaccine failures

17. Salmonella Kentucky: prevalence and challenges in Nigeria and the Africa continent

18. Epidemiological Characteristics of Meningococcal Meningitis (2016 to 2018) Four Years after the Introduction of Serogroup A Meningococcal Conjugate Vaccine in Benin

19. Validity of Enzyme-Linked Immunosorbent Assay (ELISA) as a correlate of protection of meningococcal C conjugated vaccine in adolescents with HIV infection

20. Correlating Epidemiologic Trends with the Genotypes Causing Meningococcal Disease, Maryland

21. Pericarditis Caused by Hyperinvasive Strain of Neisseria meningitidis, Sardinia, Italy, 2015

22. Capsular Switching in Invasive Neisseria meningitidis, Brazil

23. Gold(<scp>i</scp>)-promoted α-selective sialylation of glycosylortho-hexynylbenzoates for the latent-active synthesis of oligosialic acids

24. Effectiveness of a mass immunization campaign against serogroup C meningococci in children in the Federal State of Santa Catarina, Brazil

25. Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage.

26. Meningococcal C conjugate age-dependant long-term loss of effectiveness.

27. Evolving meningococcal immunization strategies.

28. Neisseria Meningitidis Urethritis in a Thai Male

29. The Impact of the Meningococcal Serogroup C Conjugate Vaccine in Canada Between 2002 and 2012.

30. Changes in meningococcal C epidemiology and vaccine effectiveness after vaccine introduction and schedule modification.

31. Evolution of ST-4821 clonal complex hyperinvasive and quinolone-resistant meningococci: the next meningococcal pandemic?

32. Phenotypic characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease in Brazil from 2002 to 2017

33. Diversity of meningococci associated with invasive meningococcal disease in the Republic of Ireland over a 19 year period, 1996-2015

34. Development of a measure to assess vaccine confidence among men who have sex with men

35. The decline of the incidence of meningococcal disease in Barcelona between 1988 and 2015: The influence of the vaccine against serogroup C

36. Meningococcal Disease Surveillance in Men Who Have Sex with Men — United States, 2015–2016

37. Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy

38. Evidence for Rise in Meningococcal Serogroup C Bactericidal Antibody Titers in the Absence of Booster Vaccination in Previously Vaccinated Children

39. Update on invasive meningococcal vaccination for Canadian children and youth

40. Outbreak of Neisseria meningitidis, Edmonton, Alberta, Canada

42. Community-Based Outbreak of Neisseria meningitidis Serogroup C Infection in Men who Have Sex with Men, New York City, New York, USA, 2010−2013

43. Immunogenicity and Safety of a Meningococcal Serogroup A, C, Y and W Glycoconjugate Vaccine, ACWY-TT.

44. Evaluation of meningococcal serogroup C conjugate vaccine programs in Canadian children: Interim analysis

45. Meningococcal Disease: Shifting Epidemiology and Genetic Mechanisms That May Contribute to Serogroup C Virulence.

46. Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults

47. Time-Series Analysis of Meningococcal Disease in Catalonia

48. A cross-sectional study assessing the pharyngeal carriage of Neisseria meningitidis in subjects aged 1–24 years in the city of Embu das Artes, São Paulo, Brazil

49. Characterisation of Neisseria meningitidis C:2b:P1.2,5 isolates in Poland.

50. Genetic characterization of a Neisseria meningitidis cluster in Queensland, Australia

Catalog

Books, media, physical & digital resources